SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-040574
Filing Date
2022-03-31
Accepted
2022-03-31 08:27:47
Documents
45
Period of Report
2022-03-31
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2210918d1_8k.htm   iXBRL 8-K 26210
2 EXHIBIT 99.1 tm2210918d1_ex99-1.htm EX-99.1 56110
6 GRAPHIC tm2210918d1_ex99-1img003.jpg GRAPHIC 200459
7 GRAPHIC tm2210918d1_ex99-1img01.jpg GRAPHIC 369458
8 GRAPHIC tm2210918d1_ex99-1img02.jpg GRAPHIC 804945
9 GRAPHIC tm2210918d1_ex99-1img04.jpg GRAPHIC 257709
10 GRAPHIC tm2210918d1_ex99-1img05.jpg GRAPHIC 346344
11 GRAPHIC tm2210918d1_ex99-1img06.jpg GRAPHIC 228663
12 GRAPHIC tm2210918d1_ex99-1img07.jpg GRAPHIC 246080
13 GRAPHIC tm2210918d1_ex99-1img08.jpg GRAPHIC 369991
14 GRAPHIC tm2210918d1_ex99-1img09.jpg GRAPHIC 227494
15 GRAPHIC tm2210918d1_ex99-1img10.jpg GRAPHIC 88403
16 GRAPHIC tm2210918d1_ex99-1img11.jpg GRAPHIC 170882
17 GRAPHIC tm2210918d1_ex99-1img12.jpg GRAPHIC 459710
18 GRAPHIC tm2210918d1_ex99-1img13.jpg GRAPHIC 194037
19 GRAPHIC tm2210918d1_ex99-1img14.jpg GRAPHIC 325627
20 GRAPHIC tm2210918d1_ex99-1img15.jpg GRAPHIC 405553
21 GRAPHIC tm2210918d1_ex99-1img16.jpg GRAPHIC 117053
22 GRAPHIC tm2210918d1_ex99-1img17.jpg GRAPHIC 373328
23 GRAPHIC tm2210918d1_ex99-1img18.jpg GRAPHIC 381290
24 GRAPHIC tm2210918d1_ex99-1img19.jpg GRAPHIC 227161
25 GRAPHIC tm2210918d1_ex99-1img20.jpg GRAPHIC 335601
26 GRAPHIC tm2210918d1_ex99-1img21.jpg GRAPHIC 38225
27 GRAPHIC tm2210918d1_ex99-1img22.jpg GRAPHIC 272960
28 GRAPHIC tm2210918d1_ex99-1img23.jpg GRAPHIC 329062
29 GRAPHIC tm2210918d1_ex99-1img24.jpg GRAPHIC 378554
30 GRAPHIC tm2210918d1_ex99-1img25.jpg GRAPHIC 285050
31 GRAPHIC tm2210918d1_ex99-1img26.jpg GRAPHIC 216112
32 GRAPHIC tm2210918d1_ex99-1img27.jpg GRAPHIC 271485
33 GRAPHIC tm2210918d1_ex99-1img28.jpg GRAPHIC 140445
34 GRAPHIC tm2210918d1_ex99-1img29.jpg GRAPHIC 56628
35 GRAPHIC tm2210918d1_ex99-1img30.jpg GRAPHIC 40139
36 GRAPHIC tm2210918d1_ex99-1img31.jpg GRAPHIC 401665
37 GRAPHIC tm2210918d1_ex99-1img32.jpg GRAPHIC 639031
  Complete submission text file 0001104659-22-040574.txt   12894366

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA egrx-20220331.xsd EX-101.SCH 3030
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE egrx-20220331_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE egrx-20220331_pre.xml EX-101.PRE 22593
39 EXTRACTED XBRL INSTANCE DOCUMENT tm2210918d1_8k_htm.xml XML 3615
Mailing Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677
Business Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677 201-326-5300
EAGLE PHARMACEUTICALS, INC. (Filer) CIK: 0000827871 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36306 | Film No.: 22789256
SIC: 2834 Pharmaceutical Preparations